Evidence map›Paper›PMID 19424877›Full record

ArticleMedical oncology (Northwood, London, England)2010

Aspirin inhibits ErbB2 to induce apoptosis in cervical cancer cells.

Shuanglin Xiang, Zhenhua Sun, Qiongzhi He, Feng Yan, Yijun Wang, Jian Zhang

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. The component formula ofOncotarget · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Antiproliferative effects of aspirin and diclofenac against the growth of cancer and fibroblast cells: In vitro comparative study.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2015
    Article
  16. Do Platelets Inhibit the Effect of Aspirin on Cancer Cells?Cancer microenvironment : official journal of the International Cancer Microenvironment Society · 2015
    Article
  17. Aspirin and Acetaminophen Use and the Risk of Cervical Cancer.Journal of lower genital tract disease · 2015
    Article
  18. Genetic association of CHEK2, GSTP1, and ERCC1 with glioblastoma in the Han Chinese population.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shuanglin XiangDepartment of Biochemistry and Molecular Biology, Key Laboratory of Protein Chemistry and Developmental Biology, Ministry of Education of China, College of Life Science, Hunan Normal University, Changsha, Hunan 410081, China.
Zhenhua Sun
Qiongzhi He
Feng Yan
Yijun Wang
Jian Zhang
Hunan Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of aspirin is associated with a lower risk of many cancer types. However, there are few reports about cervical cancer. The proto-oncogene ErbB2 is overexpressed in cervical cancer, and considered as a therapeutic target. In the present study, we investigated whether aspirin had therapeutic value in cervical cancer and examined the effects of aspirin on the amplification and expression of ErbB2. To investigate the effects of aspirin on apoptosis and proliferation, we tested apoptosis by Hoechst 33258 staining and Annexin V-FITC/PI method; MTT assay and colony formation assay were used to detect proliferation. Induction of apoptosis and inhibition of proliferation were observed in HeLa cells incubated with aspirin. Western blot and immunocytochemical staining showed that aspirin induced a dose- and time-dependent reduction of ErbB2 expression that was due to proteosome-mediated degradation of this protein. To further investigate the underlying mechanism by which aspirin exerts its apoptosis effects, we studied the ErbB2 downstream cell survival signaling pathways and the expression of anti-apoptosis gene Bcl-2. We found that aspirin inhibited the activation of extracellular signal-regulated kinase (ERK) and AKT. The inhibition of Bcl-2 expression was also observed. These data reveal that aspirin significantly induces apoptosis and inhibits proliferation, which maybe via inhibiting ErbB2 downstream cell survival signaling pathways. Taken together, our article describes a novel mechanism of action for anti-tumor activity of aspirin and implicates aspirin as a novel agent for cervical cancer.

Indexed as

ApoptosisAspirinCell Line, TumorCell SurvivalErb-b2 Receptor Tyrosine KinasesFemaleHeLa CellsHumansProto-Oncogene MasProto-Oncogene Proteins c-bcl-2Signal TransductionUterine Cervical NeoplasmsAspirinERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesMAS1 protein, humanProto-Oncogene MasProto-Oncogene Proteins c-bcl-2

Identifiers

PMID19424877
OpenAlexW2088065412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.